NARDON, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 2.578
EU - Europa 1.960
AS - Asia 1.488
SA - Sud America 307
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 55
OC - Oceania 10
Totale 6.475
Nazione #
US - Stati Uniti d'America 2.501
RU - Federazione Russa 919
SG - Singapore 644
CN - Cina 304
BR - Brasile 241
FR - Francia 213
IE - Irlanda 197
IT - Italia 170
VN - Vietnam 158
HK - Hong Kong 153
SE - Svezia 139
DE - Germania 116
GB - Regno Unito 86
KR - Corea 63
CA - Canada 45
FI - Finlandia 31
AR - Argentina 27
IN - India 26
BD - Bangladesh 22
MX - Messico 17
ID - Indonesia 16
JP - Giappone 15
PL - Polonia 15
EC - Ecuador 14
ZA - Sudafrica 14
BE - Belgio 12
IR - Iran 12
TR - Turchia 11
AT - Austria 10
CO - Colombia 10
ES - Italia 10
NL - Olanda 10
IQ - Iraq 9
AU - Australia 8
NG - Nigeria 8
LT - Lituania 7
TG - Togo 7
BJ - Benin 6
PK - Pakistan 6
MA - Marocco 5
MY - Malesia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CI - Costa d'Avorio 4
IL - Israele 4
PH - Filippine 4
PY - Paraguay 4
SA - Arabia Saudita 4
VE - Venezuela 4
CL - Cile 3
KG - Kirghizistan 3
PT - Portogallo 3
UA - Ucraina 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
SN - Senegal 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AS - Samoa Americane 1
BW - Botswana 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LV - Lettonia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 6.396
Città #
Dallas 392
Chandler 318
Ashburn 314
Moscow 296
Singapore 296
San Jose 277
Dublin 192
Hong Kong 152
Verona 101
Beijing 76
New York 75
Council Bluffs 74
Lawrence 60
Princeton 60
Ho Chi Minh City 56
Los Angeles 51
Sindelfingen 51
The Dalles 50
Kent 48
Munich 33
Buffalo 28
Hanoi 28
Santa Clara 27
Southend 26
São Paulo 24
Orem 22
Redondo Beach 22
Boardman 17
Montreal 16
San Francisco 16
Da Nang 15
Tokyo 15
Toronto 15
Chennai 14
Denver 13
Helsinki 12
Warsaw 12
Frankfurt am Main 11
Johannesburg 11
Atlanta 10
Brussels 10
Chicago 10
Lappeenranta 10
London 10
Stockholm 10
Brooklyn 9
Leawood 9
Sacramento 9
Turku 9
Belo Horizonte 8
Houston 8
West Jordan 8
Amsterdam 7
Jakarta 7
Lomé 7
Mexico City 7
Phoenix 7
Strasbourg 7
Campinas 6
Columbus 6
Cotonou 6
Lagos 6
Ninh Bình 6
Nuremberg 6
Poplar 6
São Bernardo do Campo 6
Thái Nguyên 6
Tianjin 6
Washington 6
Zanjan 6
Andover 5
Ankara 5
Barnet 5
Biên Hòa 5
Buenos Aires 5
Cleveland 5
Manchester 5
Meda 5
Philadelphia 5
Quito 5
Romola 5
Tashkent 5
Abidjan 4
Baghdad 4
Curitiba 4
Dhaka 4
Falkenstein 4
Fortaleza 4
Guarulhos 4
Hải Dương 4
Milan 4
Milwaukee 4
Rio de Janeiro 4
Rome 4
Salvador 4
Seattle 4
Thái Bình 4
Tirana 4
Asunción 3
Augusta 3
Totale 3.680
Nome #
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Ru, Ga) 194
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Au, Cu) 178
“Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” 169
Ln(III) Complexes Embedded in Biocompatible PLGA Nanoparticles as Potential Vis-to-NIR Optical Probes 156
Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” n° domanda:102016000122377, brevetto per invenzione industriale (antiflogistic), 153
An excellence in medicinal inorganic chemistry: a portrait of the gold(I/III) complexes patented for therapeutic purposes from 2010 to 2015 153
Near Infared Circularly Polarized Luminescence from water stable organic nanoparticles containing a chiral Yb(III) complex 151
Circularly Polarized Luminescence from New Heteroleptic Eu(III) and Tb(III) Complexes 146
Beyond Platinums: Gold Complexes as Anticancer Agents 146
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells 136
Cell and cell-free mechanistic studies on two gold(III) complexes with proved antitumor properties 136
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes 135
Biological studies on Au(III) peptidomimetics about to enter Phase I clinical trials 135
CuII and AuIII Complexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy 131
Editorial: Unravelling Copper-Regulatory Systems and Copper-Affected Pathways in Cancer Cells to Improve Current Therapies 130
Cellular and Computational Studies of Proteasome Inhibition and Apoptosis Induction in Human Cancer Cells by Amino Acid Schiff Base-Copper Complexes 129
DESIGN AND DEVELOPMENT OF NEW METAL-BASED BIOSENSORS FOR THE EARLY DETECTION OF CANCER ANTIGENS IN ONCOLOGY 129
Copper(II)- and Ruthenium(III)-based complexes with promising anticancer activity 126
Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations 125
20S proteasome inhibition by gold(III)-based antitumor agents: from in vitro and in vivo studies to X-ray crystallography 121
CCK8 peptide-labeled Pluronic® F127 micelles as a targeted vehicle of gold-based anticancer chemotherapeutics 120
New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway 120
CCK8 receptor-mediated cancer treatment strategies in target therapy 118
Cutting-Edge Nanosystems for Biomedical Applications 117
A new strategy in chemotherapy: preliminary studies on Cu(II) complexes aimed at exploiting the enhanced copper uptake in malignancies 117
Gold complexes for therapeutic purposes: An updated Patent review (2010-2015) 114
Cutting-edge anticancer agents: gold-based peptidomimetics targeting peptide transporters 111
Effect of the Heteroaromatic Antenna on the Binding of Chiral Eu(III) Complexes to Bovine Serum Albumin 105
Novel inorganic chemotherapeutics for cancer treatment 103
Promising Anticancer Mono- and Dinuclear Ruthenium(III) Dithiocarbamato Complexes: Systematic Solution Studies 100
NIR-emission from Yb(III)- and Nd(III)-based complexes in the solid state sensitized by a ligand system absorbing in a broad UV and visible spectral window 98
In vitro and in vivo anticancer activity of recently patented gold-based peptidomimetics targeting peptide transporters 96
Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes 91
Gold-based peptidomimetics for a targeted anticancer therapy 91
Noble metal-dithiocarbamates: precious allies in the fight against cancer 87
Design and development of new metal-based biosensors for the early detection of cancer antigens in oncology 87
Lanthanide‐Based Complexes Containing a Chiral trans‐1,2‐Diaminocyclohexane (DACH) Backbone: Spectroscopic Properties and Potential Applications 85
Studio pilota sull’efficacia di una formulazione micellare contenente un complesso di Au(III) nel trattamento dell’artrite sperimentale da collagene nel topo 85
From cisplatin to world-shattering gold(III) anticancer agents 84
Ubiquitin-Proteasome System impairment by the Gold(III) complex derivative AuL12 82
New metal-based cancer-targeting chemotherapeutics 82
Design and Development of new metal-based biosensors for the early detection of cancer antigens in oncology 79
Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts 79
Gold(III) complexes sensitize mitochondria of tumor cells to permeability transition 79
Throwing light on recent advances on metallodrugs: From deemed poisons to a striking hope for the future 76
New insights into the mechanism of action of the gold(III) dithiocarbamato complex AuL12: upstream inhibition of the ubiquitin-proteasome pathway and encapsulation in natural polysaccharides 75
Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells 73
Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics 73
Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents 73
New lanthanide-based biosensors for the early detection of cancer antigens 72
Gold(III) Complexes in the Oncological Preclinical Arena: from Aminoderivatives to Peptidomimetics 71
Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology? 71
Selective delivery of chemotherapeutics into tumor cells by use of targeting peptides 70
Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future 69
Perspective gold(III)-dithiocarbamato anticancer therapeutics: learning from the past, moving to the future 69
Ru(III) anticancer agents with aromatic and non-aromatic dithiocarbamates as ligands: Loading into nanocarriers and preliminary biological studies 67
Gold(III) dithiocarbamate complexes induce cell death triggered by thioredoxin redox system inhibition, mitochondrial permeability increase, and activation of ERK pathway 66
Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia 66
Leading-edge gold(III) targeted chemotherapeutics in translational oncology 64
Metal-based dithiocarbamato anticancer agents: an overview 63
New metal-based cancer-targeting chemotherapeutics 62
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: design and biological in vitro data 54
Gold(III) to Ruthenium(III) Metal Exchange in Dithiocarbamato Complexes Tunes Their Biological Mode of Action for Cytotoxicity in Cancer Cells 18
Exploring the effect of copper on the bioactivity of 8-quinolines: an in vitro and in vivo study 14
Totale 6.475
Categoria #
all - tutte 27.276
article - articoli 15.346
book - libri 0
conference - conferenze 8.893
curatela - curatele 0
other - altro 0
patent - brevetti 2.204
selected - selezionate 0
volume - volumi 833
Totale 54.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022279 0 0 0 0 0 0 0 0 24 57 64 134
2022/2023967 87 117 90 177 54 242 1 55 116 5 13 10
2023/2024570 16 43 62 65 42 89 72 9 2 12 104 54
2024/20251.045 44 92 45 191 28 36 22 79 74 122 61 251
2025/20263.253 229 453 183 604 780 167 218 180 213 157 39 30
2026/2027361 31 87 102 141 0 0 0 0 0 0 0 0
Totale 6.475